THESEUS PHARMACEUTICALS, INC. Deferred Tax Assets, in Process Research and Development

THESEUS PHARMACEUTICALS, INC. Deferred Tax Assets, in Process Research and Development

THESEUS PHARMACEUTICALS, INC. had Deferred Tax Assets, in Process Research and Development of $7.24 million as of 2022-12-31, per its 10-K filed 2023-03-09.

Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2023-03-09

• 2022-12-31: Deferred Tax Assets, in Process Research and Development $7.24M.